Abstract-Simultaneous measurement of Electrocardiogram (ECG) and bio-impedance (BioZ) via disposable health patches is desired for patients suffering from chronic cardiovascular and respiratory diseases. However, a sensing IC must consume ultralow power under a sub-volt supply to comply with miniaturized and disposable batteries. This work presents a 0.6V analog frontend (AFE) IC consisting of an instrumentation amplifier (IA), a current source (CS) and a SAR ADC. The AFE can measure ECG and BioZ simultaneously with a single IA by employing an orthogonal chopping scheme. To ensure the IA can tolerate up to 300mVpp DC electrode offset and 400mVpp common-mode (CM) interference, a DC-servo loop (DSL) combined with a commonmode feedforward (CMFF) loop is employed. A buffer-assisted scheme boosts the IA's input impedance by 7x to 140M at 10Hz. To improve the BioZ sensitivity, the CG utilizes dynamic element matching to reduce the 1/f noise of the output current, leading to 35m / Hz BioZ sensitivity down to 1Hz. The ADC shows a 9.7b ENOB when sampled at 20ksps. The total power consumption of the AFE is 3.8 W.
I. INTRODUCTION
Chronic cardiovascular-respiratory diseases, like congestive heart failure (CHF) and obstructive sleep apnea (OSA), require long-term, continuous and comfortable monitoring of ECG and bio-impedance (BioZ) to detect abnormal heart rate, respiration and body fluid volume. For miniaturized, lightweight and lowcost disposable patches, alternative power sources such as organic paper batteries, 3D printed batteries or thermal energy harvesters are more interesting than bulky Lithium-ion cells. However, these promising batteries usually have a low output voltage, which would require circuits also operating at sub-volt supplies to avoid excessive power management losses of boost converters. Furthermore, a low voltage analog frontend (AFE) enables better co-integration with digital cells to facilitate power efficient and on-the-node signal processing.
State-of-the-art IC solutions do not meet these requirements at the same time. Ultra-low power ICs [1] - [4] operating at 0.5-0.6V do not support BioZ and they are compromising on noise performance (e.g., [2] [3] don't meet the noise requirement of <30 Vpp defined in ANSI/AAMI/IEC60601-2-47), while highperformance multimodal ECG/BioZ ICs [5] [6] typically have 1.2-1.8V supplies and consume more power (>50 W/channel). This work presents a 0.6V 3.8 W AFE (Fig. 1) including an instrumentation amplifier (IA), a BioZ current source (CS) and a SAR ADC to facilitate simultaneous monitoring of ECG and BioZ. An orthogonal frequency modulation scheme [7] enables power-efficient ECG and BioZ measurements with a single IA. To cope with large electrode-offsets and common-mode mains interference on the 0.6V low supply, a DC-servo loop (DSL) combined with a common-mode feedforward (CMFF) path is proposed. This allows the IA to tolerate up to 300mV DC electrode offset (DEO) and 400mVpp input CM fluctuation. BioZ measurement is enabled by a wide-swing and low-noise current source (CS) equipped with regulated current mirrors and dynamic element matching (DEM). While traditional multimodal IC implementations rely on dedicated ECG and BioZ readouts, this work proposes a single amplifier-based ECG and BioZ readout (Fig. 2) . A capacitively coupled IA (CCIA) concurrently measures both signals from the same electrodes. The BioZ is measured by injecting a highfrequency (4k-128kHz) square-wave current. Hence, the ECG and modulated BioZ signals appear in different frequency bands before entering the IA. However, medically relevant BioZ spans up to 128kHz, which imposes strict BW requirements and high power consumption on the readout [6] . To overcome this issue, the modulated BioZ signal is first down-converted to an intermediate frequency (1kHz) (Fig. 2) before the CCIA and then demodulated further to DC at the output of the CCIA. The ECG signal is chopped at 4kHz, such that the fundamental and harmonic components of the ECG and BioZ signals during amplification are located at different frequency bins in an orthogonal manner. At the ECG or BioZ channel output, the desired ECG or BioZ signal is modulated back to baseband, respectively, without interfering each other. The SAR ADC is oversampled at 20ksps to avoid folding of noise and residual harmonics. This also relaxes the design of the anti-aliasing LPF in terms of its bandwidth and order. Sharing one CCIA for both ECG and BioZ channels improves system power efficiency and reduces chip area, while the orthogonal frequency modulation ensures more than 60dB signal isolation between two channels.
II. CIRCUIT IMPLEMENTATION

A. Orthognal Frequency Modulation
B. Instrumenation Amplifier (CCIA)
The biggest design challenge for a 0.6V bio-amplifier is to ensure almost rail-to-rail input and output dynamic range in the presence of large external signals (300mV DEO, baseline drift and mains CM variations). This design utilizes the CCIA (Fig.  3) because it requires near-zero voltage swing at the virtual ground. To improve power-efficiency of the CCIA, the core amplifier is based on an inverter-based input stage [3] (Fig. 4) and a class A/AB output stage with switched-capacitor CMFB. Since chopping at the virtual ground node of a CCIA increases the noise, the choppers are implemented around the capacitive feedback network. However, this modulates the DC signals at the same time, and coupling capacitors C1 would fail to reject the DEO. To solve this issue, a DSL is provided to compensate the DEO (Fig. 3) . The DC voltage at the ECG output is tracked by a Gm-C integrator and a compensation current at fc=4kHz is fed back to the virtual ground via Cfb to null the DEO current. The Gm has a complementary input (Fig. 4) to support CCIA's rail-to-rail output swing, and is chopped to reduce residual 1/f noise. Although inverter-based input stages are attractive for lowpower operation, they suffer from distortion in the presence of a large CM input signal. This is problematic for wearable biomedical applications where CM interference can be significant. Hence, a CMFF loop like [8] is used to reduce the CM swing at the virtual ground for improved linearity (Fig. 5) . However, in this work, the input CM is fed forward to the virtual ground via the DSL's SC-CMFB reference (i.e., vcmff in Fig. 4) and Cfb, instead of adding another feedback loop [8] . Hence, the noise due to multiple feedback paths is reduced. The chopping CCIAs suffer from limited input impedance formed by SC resistors. Prior work employed positive feedback loops to boost input impedance [3] [9] but they may suffer from instability and the practical boosting factor heavily depends on parasitic capacitance. In this work, the input impedance of the CCIA is boosted by two pre-charging buffers placed after the input chopper (Fig. 6) . This is similar to [8] but with a different clocking scheme. The buffers are periodically connected to the signal path for 15.625μs whenever the chopping clock switches. Hence, the spike current to charge C1 is provided by the buffers, instead of the ECG source input. This reduces the net current draw from the source and thus improves the input impedance over the entire bandwidth. In addition, this approach eliminates the risk of instability. Thanks to the duty-cycling buffers, their noise contribution is negligible. 
C. BioZ Current Source
The BioZ current source (CS) is shown in Fig. 7 . It has an output magnitude of 5 -100 A and an output frequency of 4k-128kHz. Since most BioZ activities (e.g., respiration, body fluid volume) are below 10Hz, a main design challenge is to reduce the CS's 1/f noise for improved sensitivity. Apart from noise, achieving a large compliance range under 0.6V supply is also important. This ensures that the CS remains operational when considering voltage drop over the electrode impedance, which is typically larger than the BioZ. To meet these requirements, the CS applies dynamic element matching (DEM) between all unit current mirrors. While DEM is mostly known for its use to improve matching, it has a similar effect on the 1/f noise of the devices, which will be modulated, just like the mismatch effects, to fDEM/(N+1) (Fig. 7) , where N is the current amplification factor. In this work, fDEM is selected to be 16kHz or 32kHz. The CG utilizes active cascode current mirrors to improve their voltage compliance, where two OTAs regulate the Vds of all mirror transistors to ensure their matching in triode region. The compliance voltage of the CG is 400mVpp (~67% of Vdd) at the maximum current of 100μApk The OTAs are also chopped at 8kHz to reduce their 1/f noise.
III. MEASUREMENT RESULTS
The IC is implemented in TSMC 40nm CMOS and the chip area is 1mm 2 (Fig. 8) . The readout consumes 6.3μA from 0.6V with the CS supporting current levels from 10μApp to 200μApp. In Fig. 9 , the ECG channel has a passband voltage gain of 30dB and input referred noise of 145nV/sqrt(Hz), where the BioZ channel is also enabled. The ECG/BioZ channel crosstalk is less than -60dB in a 400Hz bandwidth. With the help of two pre-charging buffers, the CCIA's input impedance is improved by 7x, from 20M to 140M at 10Hz. The CCIA also shows its robustness to the DEO (Fig. 10) . When 300mV DEO is applied, the CCIA still have less than 240nV/sqrt(Hz) input noise and a flat gain of 30dB. The BioZ channel shows 35m /sqrt(Hz) sensitivity when a 20μApp, 32kHz current is applied to a 100 test resistor. This sensitivity includes both noise of the CCIA and the CS. Another BioZ test with multiple resistors between 10-200 shows good linearity and matching with respect to the theoretical numbers.
The 13b SAR ADC achieves a 9.7b ENOB at 20ksps while consuming 400nA from 0.6V. These correspond to a FoM of 15fJ/conversion. The ADC power dissipation linearly increases with its sampling rate. The current is 10μA at 400ksps. 
